Does REVUMENIB Cause Off label use? 57 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 57 reports of Off label use have been filed in association with REVUMENIB (Revuforj). This represents 15.4% of all adverse event reports for REVUMENIB.
57
Reports of Off label use with REVUMENIB
15.4%
of all REVUMENIB reports
2
Deaths
2
Hospitalizations
How Dangerous Is Off label use From REVUMENIB?
Of the 57 reports, 2 (3.5%) resulted in death, 2 (3.5%) required hospitalization.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for REVUMENIB. However, 57 reports have been filed with the FAERS database.
What Other Side Effects Does REVUMENIB Cause?
Platelet count decreased (50)
Nausea (49)
Product dose omission issue (40)
Death (38)
Vomiting (26)
Fatigue (24)
Pyrexia (22)
Differentiation syndrome (16)
Haemoglobin decreased (16)
White blood cell count decreased (16)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which REVUMENIB Alternatives Have Lower Off label use Risk?
REVUMENIB vs REYATAZ
REVUMENIB vs REZAFUNGIN
REVUMENIB vs RIBASPHERE
REVUMENIB vs RIBAVIRIN
REVUMENIB vs RIBOCICLIB